FrancophonIA/ELRC3.0 huggingface dataset:
English: Treatment discontinuation with Spravato does not require tapering off; based on data from clinical trials the risk of withdrawal symptoms is low.
Icelandic: Samkvæmt upplýsingum úr klínískum rannsóknum er hætta á fráhvarfseinkennum lítil.
English: ● One nasal spray device delivers two sprays (one spray per nostril)
Icelandic: Úr einu nefúðatæki fást tveir úðar (einn úði í hvora nös)
English: Exposure numbers were influenced by the study stopping at a pre-determined number of relapses based on the interim analysis.
Icelandic: Rannsókninni lauk við fyrirframákveðinn fjölda bakslagstilvika sem var byggt á milligreiningu og það hafði áhrif á hversu margir fengu lyfið.
English: Following oral administration of radiolabelled esketamine, approximately 86% and 2% of administered radioactivity was recovered in urine and faeces, respectively.
Icelandic: 86% af geislavirkni í þvagi og 2% í hægðum.
English: The following EM should be provided to patients:
Icelandic: Sjúklingum á að sjá fyrir eftirfarandi fræðsluefni:
English: Majority dosing frequency Weekly
Icelandic: Vikulega eða á tveggja vikna fresti
English: Spravato can cause transient increases in systolic and/or diastolic blood pressure which peak at approximately 40 minutes after administration of the medicinal product and last approximately 1-2 hours (see section 4.8).
Icelandic: 40 mínútum eftir gjöf lyfsins og varir í u.þ.b. 1-2 klst. (sjá kafla 4.8).
English: Mean plasma esketamine Cmax and AUC∞ values produced by a single, 56-mg dose of esketamine were approximately 14% and 33% higher, respectively, in Chinese subjects compared to Caucasians.
Icelandic: Meðalgildi plasma Cmax og AUC∞ fyrir esketamin sem komu fram við stakan 56 mg skammt esketamin voru u.þ.b.
English: Remission rate
Icelandic: FYRNINGARDAGSETNING
English: ● change in sense of taste
Icelandic: ● breyting á bragðskyni
English: Difference (Spravato + oral AD minus Oral AD + placebo nasal spray) in least-squares mean change from baseline Treatment group that was statistically significantly superior to Oral AD + placebo nasal spray Median unbiased estimate (i.e., weighted combination of the LS means of the difference from Oral AD + placebo nasal spray), and 95% flexible confidence interval
Icelandic: Miðgildi óhlutdrægs mats (þ.e. vegin samsetning meðaltals minnstu fervika á muninum frá þunglyndislyfi til inntöku + lyfleysunefúði), og 95% sveigjanlegt öryggisbil
English: Spravato
Icelandic: Umbrot
English: Maintenance phase
Icelandic: - Langtímarannsóknir
English: Genotoxicity
Icelandic: Öndunarbæling
English: Allergic rhinitis
Icelandic: Ofnæmiskvef
English: GR-144 51 Athens Greece
Icelandic: GR-144 51 Athens
English: H-1114 Budapest Hungary
Icelandic: H-1114 Budapest
English: B-1800 Vilvoorde
Icelandic: B-1800 Vilvoorde Belgium
English: Novartis Sverige AB Kemistvägen 1B / Box 1150 SE-183 11 Täby Sweden
Icelandic: Novartis Sverige AB Kemistvägen 1B / Box 1150 SE-183
English: LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Icelandic: LISTI YFIR HEITI, LYFJAFORM, STYRKLEIKA LYFJANNA, ÍKOMULEIÐIR, MARKAÐSLEYFISHAFA Í AÐILDARLÖNDUNUM
English: National Road No. 1 (12th Km) Metamorphosis
Icelandic: 1 (12th Km) Metamorphosis
English: Denmark Novartis Healthcare A/S Lyngbyvej 172
Icelandic: Danmörk Novartis Healthcare A/S Lyngbyvej 172
English: Belgium N.V. Novartis Pharma S.A. Medialaan 40, bus 1
Icelandic: N.V. Novartis Pharma S.A. Medialaan 40, bus 1
English: Novartis Pharma GmbH Stella-Klein-Löw-Weg 17 AT-1020 Wien Austria
Icelandic: GmbH Stella-Klein-Löw-Weg 17 AT-1020
English: Novartis Farmacéutica S.A. Gran Via de les Corts Catalanes,
Icelandic: Gran Via de les Corts Catalanes,
English: 2-4, rue Lionel Terray 92500 RUEIL-MALMAISON, France
Icelandic: Frakkland Novartis Pharma S.A.S. 2- 4, rue Lionel Terray 92500 RUEIL-MALMAISON, France
English: Novartis (Hellas) S.A.C.I.
Icelandic: Grikkland Novartis (Hellas) S.A.C.I. National Road No.
English: Na Pankráci 1724/129 140 00 Prague 4 - Nusle Czech Republic
Icelandic: 140 00 Prague 4 - Nusle Czech Republic
English: 250mg/5ml amp
Icelandic: 250mg/5ml lykju
English: Intravenous
Icelandic: Til inntöku
English: Germany Novartis Pharma GmbH Roonstrasse 25
Icelandic: Þýskaland Novartis Pharma GmbH Roonstrasse 25
English: Novartis Finland OY Metsänneidonkuja 10 FI-02130 Espoo Finland
Icelandic: FI-02130 Espoo
English: 50mg/ml amp
Icelandic: 50mg/ml lykju
English: 0.270 mL(833 IU/mL) 1 cartridge + 1 pack with 3 pen needles
Icelandic: 1 rörlykja + 1 pakki með 3 pennanálum
English: EU/1/09/510/016 Fertavid 150 IU/0.18 mL Solution for injection Subcutaneoususe cartridge (glass)
Icelandic: 600 a.e./0,72 mL Stungulyf, lausn
English: Use caution when taking Azomyr with alcohol.
Icelandic: Gætið varúðar þegar Azomyr er tekið með áfengi.
English: Talk to your doctor, pharmacist or nurse before taking Azomyr: - if you have poor kidney function.
Icelandic: Leitið ráða hjá lækninum, lyfjafræðingi eða hjúkrunarfræðingnum áður en Azomyr notað: - ef þú ert með lélega nýrnastarfsemi.
English: Desloratadine does not inhibit CYP3A4 in vivo, and in vitro studies have shown that the medicinal product does not inhibit CYP2D6 and is neither a substrate nor an inhibitor of P-glycoprotein.
Icelandic: Deslóratadín blokkar ekki CYP3D4 in vivo, og in vitro rannsóknir hafa sýnt fram á að lyfið blokkar ekki CYP2D6 og er hvorki hvarfefni né hemill á Pglýkóprótín.
English: If you forget to take Azomyr
Icelandic: Ef gleymist að taka Azomyr
English: The prescriber should be aware that most cases of rhinitis below 2 years of age are of infectious origin (see section 4.4) and there are no data supporting the treatment of infectious rhinitis with Azomyr.
Icelandic: Læknir sem ávísar lyfinu ætti að gera sér grein fyrir að flest tilfelli nefslímubólgu hjá börnum undir 2 ára aldri eru vegna sýkinga (sjá kafla 4.4) og að engar upplýsingar liggja fyrir sem styðja meðferð með Azomyr við nefslímubólgu vegna sýkinga.
English: As Azomyr oral solution contains the same concentration of desloratadine, no bioequivalence study was required and it is expected to be equivalent to the syrup and tablet.
Icelandic: Þar sem Azomyr mixtúra, lausn, inniheldur sömu þéttni deslóratadíns var ekki þörf á sérstakri rannsókn og reiknað er með að hún sé jafngild saft og töflum.
English: There are no known interactions of Azomyr with other medicines.
Icelandic: Ekki er vitað um milliverkanir Azomyr við önnur lyf.
English: In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, Azomyr was effective in relieving pruritus and decreasing the size and number of hives by the end of the first dosing interval.
Icelandic: Í tveimur sex vikna samanburðarrannsóknum með lyfleysu á sjúklingum með langvinnan ofsakláða af óþekktum toga var Azomyr árangursríkt til að draga úr kláða og minnka umfang og fjölda ofsakláðatilfella í lok fyrsta skammtatímabilsins.
English: However, the safety of desloratadine syrup formulation, which contains the same concentration of desloratadine as Azomyr oral solution, was demonstrated in three paediatric trials.
Icelandic: Hins vegar var sýnt fram á öryggi deslóratadín saftar, sem inniheldur sömu þéttni deslóratadíns og Azomyr mixtúra, lausn í þremur rannsóknum á börnum.
English: Adverse reactions seen with Azomyr
Icelandic: Aukaverkanir sem hafa komið fram hjá Azomyr
English: What Azomyr is Azomyr contains desloratadine which is an antihistamine.
Icelandic: Hvað er Azomyr Azomyr inniheldur deslóratadín sem er andhistamín.
English: Tel: + 39 06 361911 medicalinformation.it@merck.com
Icelandic: + 39 06 361911 medicalinformation.it@merck.com
English: Azomyr 2.5 mg orodispersible tablet is light red, speckled, and round with “K” branded on one side.
Icelandic: Azomyr 2,5 mg munndreifitöflur eru ljósrauðar, doppóttar og kringlóttar, merktar „K“ á annarri hliðinni.
English: ESSEX Italia S.r.l.
Icelandic: S.r.l.
English: What Azomyr is and what it is used for What you need to know before you take Azomyr How to take Azomyr
Icelandic: Upplýsingar um Azomyr og við hverju það er notað Áður en byrjað er að nota Azomyr Hvernig nota á Azomyr
English: As a precautionary measure, it is preferable to avoid the use of Azomyr during pregnancy.
Icelandic: Til öryggis ætti að forðast notkun Azomyr á meðgöngu.
English: Azomyr contains lactose
Icelandic: Azomyr inniheldur laktósa
English: Azomyr with food, drink and alcohol Azomyr may be taken with or without a meal.
Icelandic: Notkun Azomyr með mat, drykk eða áfengi Azomyr má taka með eða án máltíðar.
English: Azomyr 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 or 100 tablets.
Icelandic: Azomyr 5 mg filmuhúðuðum töflum er pakkað í þynnur í pakkningastærðunum 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 eða 100 töflur.
English: When Azomyr should be used
Icelandic: Hvenær á að nota Azomyr
English: Azomyr is supplied in blisters comprised of laminate blister film with foil lidding.
Icelandic: Azomyr er afgreitt í álþynnum sem samanstanda af pressaðri filmu með álloki.
English: Azomyr orodispersible tablet with food, drink and alcohol Azomyr orodispersible tablet does not need to be taken with water or liquid.
Icelandic: Notkun Azomyr munndreifitöflu með mat, drykk eða áfengi Azomyr munndreifitöflu þarf ekki að taka með vatni eða öðrum vökva.
English: Azomyr 5 mg orodispersible tablet is light red, speckled, and round with “A” branded on one side.
Icelandic: Azomyr 5 mg munndreifitöflur eru ljósrauðar, doppóttar og kringlóttar, merktar „A“ á annarri hliðinni.
English: Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr.
Icelandic: Varðandi meðferðarlengd þá mun læknirinn ákvarða tegund ofnæmiskvefsins sem þú þjáist af og ákveða hve lengi þú átt að taka Azomyr.
English: Adults During the marketing of Azomyr, the following side effects were reported as:
Icelandic: Fullorðnir Greint hefur verið frá eftirfarandi aukaverkunum eftir markaðssetningu Azomyr:
English: Additionally, Azomyr orodispersible tablet may be taken with or without a meal.
Icelandic: Auk þess má taka Azomyr munndreifitöflu með eða án máltíðar.
English: Water had no effect on the bioavailability of Azomyr orodispersible tablets.
Icelandic: Vatn hafði engin áhrif á aðgengi Azomyr munndreifitaflna.
English: Azomyr oral solution with food, drink and alcohol Azomyr may be taken with or without a meal.
Icelandic: Notkun Azomyr mixtúru, lausnar, með mat, drykk eða áfengi Azomyr má taka með eða án máltíðar.
English: At the recommended dose, Azomyr 5 mg orodispersible tablet was found to be bioequivalent to the Azomyr 5 mg conventional tablet formulation of desloratadine.
Icelandic: Í ráðlögðum skammti sást að Azomyr 5 mg munndreifitafla er jafngild Azomyr 5 mg hefðbundnu töflulyfjaformi deslóratadíns.
English: Azomyr oral solution, is supplied in 30, 50, 60, 100, 120, 150, 225 and 300 ml size Type III amber glass bottles closed with a plastic child resistant (C/R) screw closure having a multi-ply polyethylenefaced liner.
Icelandic: Azomyr mixtúra, lausn, er afgreidd í 30, 50, 60, 100, 120, 150, 225 og 300 ml ljósbrúnum glerflöskum (tegund III) með pólýprópýlenöryggisskrúftappa klæddum marglaga fóðri með pólýetýlen í ysta lagi.
English: In the case of severe renal insufficiency, Azomyr should be used with caution (see section 5.2).
Icelandic: Azomyr ætti að nota með varúð ef um er að ræða alvarlega vanstarfsemi nýrna (sjá kafla 5.2).
English: What Azomyr is and what it is used for
Icelandic: Upplýsingar um Azomyr og við hverju það er notað
English: The efficacy of Azomyr tablets has not been clearly demonstrated in trials with adolescent patients 12 through 17 years of age.
Icelandic: Ekki hefur að fullu verið sýnt fram á verkun Azomyr taflna í rannsóknum á sjúklingum á aldrinum 12 til 17 ára.
English: Adults and adolescents (12 years of age and over) The recommended dose of Azomyr is one tablet once a day.
Icelandic: Fullorðnir og unglingar (12 ára og eldri) Ráðlagður skammtur af Azomyr er ein tafla einu sinni á sólarhring.
English: The recommended dose of Azomyr is one 5 mg orodispersible tablet placed in the mouth once a day.
Icelandic: Ráðlagður skammtur af Azomyr er ein 5 mg munndreifitafla látin í munn einu sinni á dag.
English: Azomyr effectively controlled symptoms for 24 hours.
Icelandic: Azomyr dró úr einkennum í 24 klukkustundir.
English: Tel: +420 233 010 111 dpoc_czechslovak@merck.com
Icelandic: Tel: +420 233 010 111 msd_cr@merck.com
English: How Azomyr works
Icelandic: Hvernig virkar Azomyr
English: Efficacy of Azomyr syrup has not been investigated in paediatric trials in children less than 12 years of age.
Icelandic: Azomyr saftar hefur ekki verið rannsökuð hjá börnum yngri en 12 ára í klínískum rannsóknum.
English: In a clinical pharmacology trial, Azomyr tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1).
Icelandic: Azomyr taflna samtímis alkóhóli ekki skerðandi áhrif alkóhóls á frammistöðu (sjá kafla 5.1).
English: Treatment with Azomyr also significantly reduced interference with sleep and daytime function, as measured by a four-point scale used to assess these variables.
Icelandic: Meðhöndlun með Azomyr dró einnig marktækt úr svefntruflunum og truflunum á starfsgetu, en þær breytur eru mældar og ákvarðaðar á kvarðanum núll til fjórir.
English: Children 1 through 5 years of age: 2.5 ml (1.25 mg) Azomyr oral solution once a day.
Icelandic: 2,5 ml (1,25 mg) Azomyr mixtúra, lausn, einu sinni á dag.
English: Azomyr is an antiallergy medicine that does not make you drowsy.
Icelandic: Azomyr er ofnæmislyf sem veldur ekki syfju.
English: Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr orodispersible tablets.
Icelandic: Varðandi meðferðarlengd þá mun læknirinn ákvarða tegund ofnæmiskvefsins sem þú þjáist af og ákveða hve lengi þú átt að taka Azomyr munndreifitöflu.
English: Other medicines and Azomyr
Icelandic: Notkun annarra lyfja samhliða Azomyr
English: The safety and efficacy of Azomyr 5 mg film-coated tablets in children below the age of 12 years have not been established.
Icelandic: Ekki hefur verið sýnt fram á öryggi og verkun Azomyr 5 mg filmuhúðaðra taflna hjá börnum yngri en 12 ára.
English: Do not use this medicine if you notice any change in the appearance of Azomyr orodispersible tablet.
Icelandic: Ekki skal nota lyfið ef einhverjar breytingar eru á útliti Azomyr munndreifitaflna.
English: What Azomyr orodispersible tablet is and what it is used for What you need to know before you take Azomyr orodispersible tablet How to take Azomyr orodispersible tablet Possible side effects
Icelandic: Upplýsingar um Azomyr mixtúru, lausn, og við hverju hún er notuð Áður en byrjað er að nota Azomyr mixtúru, lausn Hvernig nota á Azomyr mixtúru, lausn Hugsanlegar aukaverkanir
English: How to store Azomyr
Icelandic: Hvernig geyma á Azomyr
English: Azomyr has no or negligible influence on the ability to drive and use machines based on clinical trials.
Icelandic: Samkvæmt klínískum rannsóknum hefur Azomyr engin eða óveruleg áhrif á hæfni til aksturs og notkunar véla.
English: How to store Azomyr oral solution Contents of the pack and other information
Icelandic: Hugsanlegar aukaverkanir Hvernig geyma á Azomyr Pakkningar og aðrar upplýsingar
English: Azomyr tablets given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Icelandic: Azomyr töflur gefnar í einum 7,5 mg skammti daglega höfðu engin áhrif á skynhreyfigetu í klínískum rannsóknum.
English: Azomyr 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Azomyr orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.
Icelandic: Azomyr 2,5 mg töflur hafa ekki verið metnar hjá börnum, en í rannsóknum á skömmtum hjá börnum hafa rannsóknir á lyfjahvörfum
English: The safety and efficacy of Azomyr 2.5 mg orodispersible tablets in children below the age of 6 years have not been established.
Icelandic: Ekki hefur verið sýnt fram á öryggi og verkun Azomyr 2,5 mg munndreifitaflna hjá börnum yngri en 6 ára.
English: 6.1 List of excipients sorbitol, propylene glycol, sucralose E 955, hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour (bubblegum), citric acid anhydrous, disodium edetate, purified water
Icelandic: própýlenglýkól, súkralósi E 955, hýprómellósi 2910 natríumsítrattvíhýdrat, náttúrulegt og gervibragðefni (tyggigúmmí), vatnsfrí sítrónusýra, tvínatríum edetat, hreinsað vatn
English: A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Azomyr therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Icelandic: Vega þarf og meta kosti brjóstagjafar fyrir barnið og ávinning meðferðar fyrir konuna og ákveða á grundvelli matsins hvort hætta eigi brjóstagjöf eða hætta/stöðva tímabundið meðferð með Azomyr.
English: If you forget to take Azomyr oral solution
Icelandic: Ef gleymist að taka Azomyr mixtúru, lausn
English: The safety and efficacy of Azomyr 0.5 mg/ml oral solution in children below the age of 1 year have not been established.
Icelandic: Ekki hefur verið sýnt fram á öryggi og verkun Azomyr 0,5 mg/ml mixtúru, lausnar, hjá börnum yngri en 1 árs.
English: What Azomyr orodispersible tablet is and what it is used for
Icelandic: Upplýsingar um Azomyr munndreifitöflu og við hverju hún er notuð
English: Azomyr orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Icelandic: Azomyr mixtúra, lausn, er einnig notuð til að draga úr einkennum ofsakláða (einkenni í húð vegna ofnæmis).
English: In single-dose crossover studies of Azomyr 5 mg orodispersible tablets with Azomyr 5 mg conventional tablets, the formulations were bioequivalent.
Icelandic: Í stakskammtavíxlrannsóknum á 5 mg Azomyr munndreifitöflum með hefðbundnum 5 mg Azomyr töflum voru lyfjaformin jafngild.
English: Azomyr is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Icelandic: Azomyr er einnig notað til að draga úr einkennum ofsakláða (einkenni í húð vegna ofnæmis).
English: Taking Azomyr is not recommended if you are pregnant or nursing a baby.
Icelandic: Ekki er ráðlagt að taka Azomyr á meðgöngu eða meðan á brjóstagjöf stendur.
English: If you take more Azomyr orodispersible tablet than you should Take Azomyr orodispersible tablet only as prescribed for you.
Icelandic: Ef tekinn er stærri skammtur af Azomyr mixtúru, lausn, en mælt er fyrir um Takið Azomyr mixtúruna eingöngu eins og ávísað er.
English: Azomyr is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Icelandic: Azomyr er ætlað fullorðnum, unglingum 12 ára og eldri og börnum á aldrinum 6-11 ára til að draga úr einkennum: - ofnæmiskvefs (sjá kafla 5.1) - ofsakláða (sjá kafla 5.1)
English: In clinical studies in most children and adults, side effects with Azomyr were about the same as with a dummy solution or tablet.
Icelandic: Í klínískum rannsóknum hjá flestum börnum og fullorðnum voru aukaverkanir u.þ.b. þær sömu og vegna lyfleysumixtúru og lyfleysutaflna.
English: EU/1/00/157/059 30 ml with 1 spoon EU/1/00/157/060 50 ml with 1 spoon EU/1/00/157/061 60 ml with 1 spoon EU/1/00/157/062 100 ml with 1 spoon EU/1/00/157/063 120 ml with 1 spoon EU/1/00/157/064 150 ml with 1 spoon EU/1/00/157/067 150 ml with 1 oral syringe EU/1/00/157/065 225 ml with 1 spoon EU/1/00/157/066 300 ml with 1 spoon
Icelandic: EU/1/00/157/059 30 ml með 1 mæliskeið EU/1/00/157/060 50 ml með 1 mæliskeið EU/1/00/157/061 60 ml með 1 mæliskeið EU/1/00/157/062 100 ml með 1 mæliskeið EU/1/00/157/063 120 ml með 1 mæliskeið EU/1/00/157/064 150 ml með 1 mæliskeið EU/1/00/157/067 150 ml með 1 inntökusprautu EU/1/00/157/065 225 ml með 1 mæliskeið EU/1/00/157/066 300 ml með 1 mæliskeið
English: If you forget to take Azomyr orodispersible tablet If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing schedule.
Icelandic: Ef gleymist að taka skammtinn einu sinni, skal taka hann eins fljótt og auðið er, síðan er lyfið tekið eftir skammtaáætlun.
English: - If you have any further questions, ask your doctor, pharmacist or nurse - This medicine has been prescribed for you only.
Icelandic: - Leitið til læknisins, lyfjafræðings eða hjúkrunarfræðingsins ef þörf er á frekari upplýsingum.
English: Azomyr 0.5 mg/ml oral solution desloratadine
Icelandic: Azomyr 0,5 mg/ml mixtúra, lausn deslóratadín
English: EU/1/00/157/001 1 tablet EU/1/00/157/002 2 tablets EU/1/00/157/003 3 tablets EU/1/00/157/004 5 tablets EU/1/00/157/005 7 tablets EU/1/00/157/006 10 tablets EU/1/00/157/007 14 tablets EU/1/00/157/008 15 tablets EU/1/00/157/009 20 tablets EU/1/00/157/010 21 tablets EU/1/00/157/011 30 tablets EU/1/00/157/012 50 tablets EU/1/00/157/013 100 tablets
Icelandic: EU/1/00/157/001 1 tafla EU/1/00/157/002 2 töflur EU/1/00/157/003 3 töflur EU/1/00/157/004 5 töflur EU/1/00/157/005 7 töflur EU/1/00/157/006 10 töflur EU/1/00/157/007 14 töflur EU/1/00/157/008 15 töflur EU/1/00/157/009 20 töflur EU/1/00/157/010 21 tafla EU/1/00/157/011 30 töflur EU/1/00/157/012 50 töflur EU/1/00/157/013 100 töflur
English: If you take more Azomyr oral solution than you should Take Azomyr oral solution only as it is prescribed for you.
Icelandic: Ef tekinn er stærri skammtur en mælt er fyrir um Takið Azomyr eingöngu eins og ávísað er.
English: What Azomyr oral solution is and what it is used for
Icelandic: Upplýsingar um Azomyr mixtúru, lausn, og við hverju hún er notuð
English: Therefore, the efficacy of Azomyr orodispersible tablet is expected to be the same as with the Azomyr tablet formulation.
Icelandic: Þess vegna er gert ráð fyrir að Azomyr munndreifitafla verki á sama hátt og lyfjaformið Azomyr töflur.
English: Azomyr tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials.
Icelandic: Azomyr töflur gefnar fullorðnum og unglinum í einum 7,5 mg skammti daglega höfðu engin áhrif á skynhreyfigetu í klínískum rannsóknum.
English: How to take Azomyr
Icelandic: Hvernig nota á Azomyr
English: In patients with allergic rhinitis, Azomyr was effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Icelandic: Hjá sjúklingum með ofnæmiskvef var Azomyr árangursríkt til að draga úr einkennum eins og hnerra, nefrennsli og kláða, ásamt augnkláða, tárarennsli og roða í augum og kláða í efri góm.
English: Azomyr given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Icelandic: Gjöf 7,5 mg af Azomyr í einum skammti daglega hafði engin áhrif á skynhreyfigetu í klínískum rannsóknum.
English: Azomyr 5 mg tablet desloratadine
Icelandic: Azomyr 5 mg tafla deslóratadín
English: Azomyr oral solution contains sorbitol
Icelandic: Azomyr mixtúra, lausn inniheldur sorbitól
English: Azomyr orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding.
Icelandic: Azomyr munndreifitöflur eru afgreiddar í stakskammtaþynnum sem samanstanda af pressaðri filmu með álloki.
English: This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Azomyr orodispersible tablet.
Icelandic: Í 2,5 mg Azomyr munndreifitöflu eru 1,4 mg af fenýlalaníni.
English: Do not take Azomyr - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Icelandic: Ekki má nota Azomyr - ef um er að ræða ofnæmi fyrir deslóratadíni eða einhverju öðru innihaldsefni lyfsins (talin upp í kafla 6) eða lóratadíni.